Are survival outcomes dependent on the tumour dose threshold of 139 Gy in patients with chemorefractory metastatic colorectal cancer treated with yttrium-90 radioembolization using glass particles? A real-world single-centre study.
Osman Melih TopçuoğluTolga OrhanAyşegul GormezNalan AlanPublished in: The British journal of radiology (2024)
This study demonstrated that increased tumour absorbed doses in radioembolization may not provide additional significant advantage for OS and hPFS for patients with CRCLM.
Keyphrases